CAC
GWPH

Cowen and Company’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Cowen and Company’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,500
Closed -$26K – 740
2020
Q4 		$26K Sell
5,500
-2,000
-27% -$224K ﹤0.01% 312
2020
Q3 		$93K Buy
+7,500
New +$863K 0.02% 264

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Cowen and Company's GWPH Position: Q4 2020 in Review

Cowen and Company sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2020, closing a stake of 5,823 shares — an estimated $652K sold.

Cowen and Company first reported a position in GWPH in Q3 2020 and held it in 1 quarter. The position peaked at $567K in Q3 2020. 279 funds tracked by Wall St. Rank hold GWPH as of Q4 2020.

  • Cowen and Company reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • Cowen and Company sold 5,823 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2020, an estimated $652K.
  • Cowen and Company first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2020 and held it in 1 quarter.
  • Cowen and Company's GW Pharmaceuticals Plc American Depositary Shares position peaked at $567K in Q3 2020.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2020.

Based on Cowen and Company's 13F filing for Q4 2020, filed 8 Feb 2021.